Total Payout Yield % is the percent a company has paid to its shareholders through net repurchases of shares and dividends based on its Market Cap. It is a measure of shareholder return.
Bone Biologics's current Total Payout Yield % is -351.39%.
Bone Biologics Total Payout Yield % Historical Data
The historical data trend for Bone Biologics's Total Payout Yield % can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Competitive Comparison of Bone Biologics's Total Payout Yield %
For the Medical Devices subindustry, Bone Biologics's Total Payout Yield %, along with its competitors' market caps and Total Payout Yield % data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Bone Biologics's Total Payout Yield % Distribution in the Medical Devices & Instruments Industry
For the Medical Devices & Instruments industry and Healthcare sector, Bone Biologics's Total Payout Yield % distribution charts can be found below:
* The bar in red indicates where Bone Biologics's Total Payout Yield % falls into.
Bone Biologics Total Payout Yield % Calculation
Total Payout Yield % is a measure of shareholder return.
Bone Biologics's Total Payout Yield % for the fiscal year that ended in Dec. 2023 is calculated as
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Bone Biologics Total Payout Yield % Explanation
Similar to Dividend Yield, Total Payout Yield % is a measurement of shareholder return. Dividends is not the only way that companies are able to distribute their excess cash back to the shareholders. The other way to distribute the cash is a stock repurchase. The stock repurchase buys back the company's own shares from the marketplace. This results in a reduced number of oustanding shares, making each share worth a greater percentage of the corporation.
Bone Biologics Total Payout Yield % Related Terms
Thank you for viewing the detailed overview of Bone Biologics's Total Payout Yield % provided by GuruFocus.com. Please click on the following links to see related term pages.
Bone Biologics (Bone Biologics) Business Description
Bone Biologics Corp is a healthcare solutions provider based in the United States. As a biotechnology firm, it engages its efforts in developing therapeutics to aid bone regeneration. The company's portfolio comprises its lead product, NELL-1, which is a bone void filler. Bone Biologics' technology has application in the surgical specialties of spinal, orthopedic, general orthopedic, plastic reconstruction, neurosurgery, interventional radiology, and sports medicine.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
Portfolio Contest
BBLG has been successfully added to your 